相关实验视频

Updated: Jan 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

一种新型的MYH9突变相关的宏血栓细胞缺陷症:一个病例系列

Sarthak Wadhera¹, Ritika Sharma², Aarushi Sahni³

¹Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

|September 11, 2025

概括

与MYH9相关的疾病是一种罕见的遗传性出血障碍,可以被误诊为ITP. 鉴定出一种新的MYH9变体,而血栓形成素受体激动剂对受影响的个体显示出治疗效益.

科学领域:

遗传学是一个遗传学.
血液学血液学血液学
罕见疾病罕见疾病

背景情况:

与MYH9相关的疾病 (MYH9-RD) 呈现出宏血缩和潜在的听力损失,脏问题或白内障.
表型与免疫性血小板缺血 (ITP) 的重叠经常导致错误诊断和不正确的治疗.

研究的目的:

为了记录一个新的MYH9基因变异在一个家族与综合征性宏观血栓细胞缺陷症.
为了证明血栓形成素受体激活剂在治疗症状病例中的有效性.

主要方法:

下一代测序 (NGS) 在索引案例中发现了一种新型异构合的MYH9变体 (c.130_131delinsAA; p.Ala44Asn).
在四个受影响的家庭成员中证实了变种的分离,他们有不同的症状.
在接受Eltrombopag治疗的个体中评估了临床结果.

主要成果:

鉴定出一种新的致病性MYH9变体,在家族中与综合征性宏观血小板缺血症分离.
两个家庭成员有感觉神经听力损失 (SNHL),一个人患有白内障.
在有症状的患者中,ELTROMBOPAG治疗导致了血小板数量的改善和止血.

结论:

这项研究确定了一种新的MYH9变体,与综合征性宏观血栓细胞衰减有关.
早期诊断遗传性血小板缺血是防止不正确的免疫抑制疗法至关重要的.
适当的管理包括血栓形成素受体激动剂,遗传咨询和监测血液外并发症.

关键词:

遗传性血小板缺血症遗传性血小板缺血症这是MYH9-RDD.宏观血栓细胞缺血症是什么

更多相关视频

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...